Year: 2022

News

Million Hearts® Stakeholders Flu Vaccination Campaign

With a potentially severe flu season upon us, it is more important than ever to encourage our communities to get their flu shots. You and your team can access valuable…

New Amgen Data at ESC 2022 Show Long-Term LDL-C Lowering with REPATHA® (EVOLOCUMAB) was well-tolerated for more than 8 years

THOUSAND OAKS, Calif., Aug. 29, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) today presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha® (evolocumab) in adults with atherosclerotic cardiovascular disease (ASCVD)…

Pfizer and BioNTech Submit Application to U.S. FDA for Emergency Use Authorization of Omicron BA.4/BA.5-Adapted Bivalent COVID-19 Vaccine

NEW YORK & MAINZ, Germany–(BUSINESS WIRE)– Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced they have completed a submission to the U.S. Food and Drug Administration (FDA) requesting Emergency Use Authorization…

Dr. Lewis, Breathett, Clair, and Okafor Appointed to New Equity, Diversity and Inclusion Editorial Board

A new Equity, Diversity and Inclusion Editorial Board was announced in the American Heart Association’s second annual Disparities issue in the journal Circulation. Eldrin F. Lewis, MD, MPH, Khadijah Breathett, MD,…

ABC Members Featured in JAHA’s Second Annual Disparities Issue

American Heart Association The American Heart Association’s flagship journal Circulation published its second annual issue devoted to disparities in cardiovascular medicine. The special issue is a complementary collection of On…

ACC Names Dr. Melvin Echols as Chief Diversity, Equity and Inclusion Officer

THOUSAND OAKS, Calif., Aug. 29, 2022 /PRNewswire/ — Amgen (NASDAQ:AMGN) today presented new compelling data from the Phase 3 FOURIER open label extension (OLE) studies of Repatha® (evolocumab) in adults with atherosclerotic cardiovascular disease (ASCVD)…